-
-
-
-
-
-
-
Arcutis' ZORYVE cream gets strong AAD recommendation for pediatric atopic dermatitis
-
-
-
-
-
-
-
Arcutis projects ZORYVE sales of $455-470 million for 2026
-
-
-
-
-
-
-
Arcutis Biotherapeutics Inc. (ARQT) PT Raised to $30 at H.C. Wainwright
-
-
-
-
-
-
-
Arcutis Biotherapeutics, Inc. (ARQT) Tops Q2 EPS by 4c
-
-
-
-
-
-
-
Arcutis Biotherapeutics Inc. (ARQT) PT Raised to $20 at Jefferies
-
-
-
-
-
-
-
Arcutis Biotherapeutics Inc. (ARQT) PT Raised to $21 at Mizuho
-
-
-
-
-
-
-
Arcutis Biotherapeutics (ARQT) Promotions on Executive Management Team
-
445,862 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

